CDK7 inhibition suppresses MYC-dependent cancer

被引：0
|
作者：
Sarah Crunkhorn
机构：
来源：
Nature Reviews Drug Discovery | 2015年 / 14卷 / 1期
关键词：
D O I：
10.1038/nrd4513
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：16 / 16
相关论文
共 50 条
  • [1] Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13
    Zeng, Mei
    Kwiatkowski, Nicholas P.
    Zhang, Tinghu
    Nabet, Behnam
    Xu, Mousheng
    Liang, Yanke
    Quan, Chunshan
    Wang, Jinhua
    Hao, Mingfeng
    Palakurthi, Sangeetha
    Zhou, Shan
    Zeng, Qing
    Kirschmeier, Paul T.
    Meghani, Khyati
    Leggett, Alan L.
    Qi, Jun
    Shapiro, Geoffrey I.
    Liu, Joyce F.
    Matulonis, Ursula A.
    Lin, Charles Y.
    Konstantinopoulos, Panagiotis A.
    Gray, Nathanael S.
    ELIFE, 2018, 7
  • [2] CDK7 INHIBITION IN AT/RT
    Morin, Andrew
    Veo, Bethany
    Fosmire, Susan
    Crespo, Michele
    Zahedi, Shadi
    Vibhakar, Rajeev
    Levy, Jean M. Mulcahy
    NEURO-ONCOLOGY, 2020, 22 : 279 - 280
  • [3] CDK7 INHIBITION IN AT/RT
    Morin, Andrew
    Wodetzki, Darya
    Veo, Bethany
    Pierce, Angela
    Zahedi, Shadi
    Crespo, Michele
    Venkataraman, Sujatha
    Vibhakar, Rajeev
    Mulcahy-Levy, Jean
    NEURO-ONCOLOGY, 2022, 24 : 8 - 8
  • [4] CDK7 INHIBITION DISRUPTS ACQUIRED RESISTANCE MECHANISMS IN MYC-MB
    Veo, Bethany
    Wang, Dong
    Michlin, Joshua
    Wimsatt, Genevieve
    Vibhakar, Rajeev
    NEURO-ONCOLOGY, 2024, 26
  • [5] CDK7 inhibition suppresses aberrant hedgehog pathway and overcomes resistance to smoothened antagonists
    Liu, Fang
    Jiang, Wenyan
    Sui, Yi
    Meng, Wei
    Hou, Linjun
    Li, Tiantian
    Li, Meng
    Zhang, Lei
    Mo, Jialin
    Wang, Jiajia
    Zhao, Yang
    Zhang, Liye
    Ma, Jie
    Tang, Yujie
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2019, 116 (26) : 12986 - 12995
  • [6] CDK7 Inhibition Suppresses Super-Enhancer-Linked Oncogenic Transcription in MYCN-Driven Cancer
    Chipumuro, Edmond
    Marco, Eugenio
    Christensen, Camilla L.
    Kwiatkowski, Nicholas
    Zhang, Tinghu
    Hatheway, Clark M.
    Abraham, Brian J.
    Sharma, Bandana
    Yeung, Caleb
    Altabef, Abigail
    Perez-Atayde, Antonio
    Wong, Kwok-Kin
    Yuan, Guo-Cheng
    Gray, Nathanael S.
    Young, Richard A.
    George, Rani E.
    CELL, 2014, 159 (05) : 1126 - 1139
  • [7] CDK7 blockade suppresses super‐enhancer‐associated oncogenes in bladder cancer
    Yafei Yang
    Donggen Jiang
    Ziyu Zhou
    Haiyun Xiong
    Xiangwei Yang
    Guoyu Peng
    Wuchao Xia
    Shang Wang
    Hanqi Lei
    Jing Zhao
    Zhirong Qian
    Song Wu
    Jun Pang
    Cellular Oncology, 2021, 44 : 871 - 887
  • [8] CDK7 Inhibition Suppresses Castration-Resistant Prostate Cancer through MED1 Inactivation
    Rasool, Reyaz Ur
    Natesan, Ramakrishnan
    Deng, Qu
    Aras, Shweta
    Lal, Priti
    Effron, Samuel Sander
    Mitchell-Velasquez, Erick
    Posimo, Jessica
    Carskadon, Shannon
    Baca, Sylvan C.
    Pomerantz, Mark M.
    Siddiqui, Javed
    Schwartz, Lauren E.
    Lee, Daniel J.
    Palanisamy, Nallasivam
    Narla, Goutham
    Den, Robert B.
    Freedman, Matthew L.
    Brady, Donita C.
    Asangani, Irfan A.
    CANCER DISCOVERY, 2019, 9 (11) : 1538 - 1555
  • [9] CDK7 inhibition augments response to multidrug chemotherapy in pancreatic cancer
    Siyuan Zeng
    Bin Lan
    Xiaofan Ren
    Shuman Zhang
    Daniel Schreyer
    Markus Eckstein
    Hai Yang
    Nathalie Britzen-Laurent
    Andreas Dahl
    Debabrata Mukhopadhyay
    David Chang
    Isabella Kutschick
    Susanne Pfeffer
    Peter Bailey
    Andrew Biankin
    Robert Grützmann
    Christian Pilarsky
    Journal of Experimental & Clinical Cancer Research, 41
  • [10] CDK7 inhibition augments response to multidrug chemotherapy in pancreatic cancer
    Zeng, Siyuan
    Lan, Bin
    Ren, Xiaofan
    Zhang, Shuman
    Schreyer, Daniel
    Eckstein, Markus
    Yang, Hai
    Britzen-Laurent, Nathalie
    Dahl, Andreas
    Mukhopadhyay, Debabrata
    Chang, David
    Kutschick, Isabella
    Pfeffer, Susanne
    Bailey, Peter
    Biankin, Andrew
    Gruetzmann, Robert
    Pilarsky, Christian
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2022, 41 (01)
12345